Daily Archives: May 22, 2018


tofacitinib (Xeljanz)

Generic Name: tofacitinib Brand Name: Xeljanz Manufacturer: Pfizer Canada Inc. Indications: Ulcerative colitis Manufacturer Requested Reimbursement Criteria1: ​Indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) with an inadequate response, loss of response or intolerance to either conventional UC therapy or a biological agent […]